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Articles

Eﬀect of a knowledge-based and skills-based programme for
physicians on risk of sexually transmitted reinfections
among high-risk patients in China: a cluster randomised trial
Don Operario, Debin Wang, Nickolas D Zaller, Mei-Fen Yang, Kathleen Blaney, Jing Cheng, Qian Hong, Hongbo Zhang, Jing Chai, Gregory Szekeres,
Jerome Galea, Thomas J Coates

Summary
Background China is experiencing growing epidemics of HIV and sexually transmitted infections (STIs). Programmes
to train physicians in China on HIV and STI knowledge, diagnosis, treatment, and risk reduction counselling can
potentially reduce HIV and STI risk among high-risk patients. We aimed to assess a knowledge-based and skillsbased programme for physicians in China to reduce patients’ STI risk.
Methods In this cluster randomised trial, we block randomised counties in two provinces in eastern China to
intervention or control groups. In the intervention group, physicians from county general hospitals participated in a
structured HIV and STI training programme and received opportunities to enhance their clinical and counselling
skills, whereas in the control group, physicians from county hospitals received the training after the intervention
group completed ﬁnal assessments. We recruited STI patients from physicians in both groups, treated baseline
gonorrhoea and chlamydia infections, and assessed 9-month gonorrhoea and chlamydia reinfection as the primary
outcome. Statistical comparisons between intervention and delayed-control patients used multilevel analyses to
account for cluster eﬀects at county and physician levels. Analysis was by intention to treat. This study is registered
with ClinicalTrials.gov, NCT00644150.
Findings Between April 1, 2007, and Sept 1, 2008, 51 counties were randomly assigned; 27 to receive immediate
intervention and 24 to receive delayed intervention. 249 physicians from the 51 county-level hospitals were enrolled,
121 physicians in the intervention group and 128 in the control group. From these physicians, we enrolled 633 and
491 patients, respectively, of whom 508 (80%) and 402 (82%) were available for reassessment at 9 months. Intervention
patients at follow-up had signiﬁcantly lower odds of combined gonorrhoea or chlamydia reinfection than did control
patients (58/508 [11%] vs 123/402 [31%]; adjusted odds ratio 0·62 [95% CI 0·46–0·84]).
Interpretation Integrating HIV and STI training into medical education in China could be an eﬀective strategy to
reduce the country’s growing HIV risk and STI epidemics.
Funding US National Institutes of Health.
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Introduction
HIV in China has evolved from an epidemic mainly
associated with contaminated red-cell infusion after blood
donation and injection drug use to an epidemic
increasingly characterised by sexual transmission.1–4
Although early HIV cases in China were geographically
concentrated, during the previous decade the epidemic has
spread throughout all of China’s 31 provinces, autonomous
regions, and municipalities (excluding Hong Kong,
Macau, and Taiwan). The Chinese Government has
responded to the growing epidemic with assertive public
health policies, such as the 2006 AIDS Prevention and
Control Regulations, which include initiatives to provide
free antiretroviral treatment and HIV testing, support
syringe distribution and drug treatment programmes,
promote condom use, and reduce AIDS stigma.5–8
Implementation of China’s national AIDS policies
relies on physicians to deliver prevention and treatment
www.thelancet.com/lancetgh Vol 4 January 2016

of HIV and sexually transmitted infections (STIs) in
routine practice, including HIV testing, symptom
diagnosis, treatment recommendations, and risk
reduction counselling.9–11 However, there are serious
gaps in physicians’ knowledge and skills in diagnosing
and treating HIV and STIs.12–17 Interventions to increase
the ability of Chinese physicians to counsel and to treat
patients at risk of HIV and STIs have shown
improvements in physicians’ HIV/STI knowledge and
clinical skills at follow-up.18–20 These studies have not,
however, been tested using controlled designs or
corroborated with patient-level outcomes. A recent
randomised trial done in China showed the eﬃcacy of
an intervention to reduce physicians’ stigmatising
attitudes and behaviours towards people living
with HIV,21 suggesting that HIV/AIDS interventions
targeting physicians can improve interactions
with patients.
e29
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We assessed a knowledge and skills-based programme
for physicians in China to reduce patients’ HIV and STI
risk. Physicians were trained in HIV and STI transmission,
diagnosis, treatment, and patient-centred risk reduction
counselling. The programme, entitled Ai Shi Zi (meaning
“AIDS Plus” in Mandarin) views physicians as important
agents of change to reduce HIV and STI transmission and
risk behaviours among high-risk patients in China. The
training curriculum is based on social learning theory,
which emphasises interactive learning, modelling of
behavioural skills, self-eﬃcacy, goal setting, and knowledge
as determinants of behaviour change.22 We conducted the
intervention in Anhui and Jiangsu, geographically
contiguous provinces in eastern China. Both provinces
have expanding HIV and STI epidemics, with unprotected
sexual behaviour as a primary risk factor of transmission.23–25
Our primary hypothesis was a reduction in STI reinfection
(gonorrhoea and chlamydia) among patients of physicians
who received the intervention compared with patients of
physicians in a control group who received the intervention
after a delay. We also hypothesised improvements in
knowledge about HIV and STI transmission, attitudes,
satisfaction with physicians, and condom use among
patients in the intervention group compared with those in
the control group.

Methods
Study design and participants
In this cluster-randomised trial, counties were assigned
to intervention or control groups. Cluster randomisation
was used to account for interaction, and potential
contamination, among physicians within hospital
settings. We contacted administrators of county-level
general hospitals in Anhui and Jiangsu provinces to
inform them about the study and to solicit their interest
in allowing hospital physicians to participate. There was
one general hospital per county. We randomly assigned
counties to either the intervention group, in which
groups of county-level general hospital physicians
received the training immediately, or to the control group
in which physicians received the training after physicians
in the intervention counties completed the study; a
delayed control group was deemed appropriate to ensure
that all physicians enrolled in the study had access to the
information provided in the training. The Ethical Review
Boards of Anhui Medical University and UCLA approved
the study, and we obtained written informed consent
from all participants.
To recruit physicians, we enlisted the provincial health
bureaus to issue a formal invitation to participating
county general hospitals. The announcement speciﬁed
the purposes of the project, physician eligibility criteria,
the fact that participation was entirely voluntary, and that
some counties would receive training immediately and
that training for other counties would be delayed.
Hospitals were not paid to participate. County-level
physicians were eligible if they were employed at a
e30

county-level general hospital; specialised in STIs,
obstetrics, gynaecology, or HIV care; had a minimum
3 years of clinical experience; had ever treated patients
with HIV or STIs; and were willing to complete the
intervention training programme. All costs associated
with transportation and lodging were paid for, but
participating physicians were not given ﬁnancial
compensation for taking part in the intervention.
Research assistants recruited patients from waiting
rooms of participating physicians. Between three and
ten patients were recruited from each physician. Patients
were informed about the study and those who expressed
interest were asked to provide a urine sample to test for
gonorrhoea and chlamydia and to return to the county
hospital in 2 weeks for test results. All patients who
tested positive received treatment free of charge
regardless of enrolment, and those expressing continued
interest were referred to a study intake coordinator.
Patients were eligible if they tested baseline-positive for
gonorrhoea or chlamydia, received treatment, were at
least 18 years old, received patient services from a
physician who participated in the training programme,
and were not planning to relocate in the next 9 months.
Patients in the intervention group were recruited after
their physicians had completed the ﬁnal 9-month
training assessment. Patients in the control group were
recruited and completed their 9-month follow-up before
their physicians started the training. Based on this
design, patient group diﬀerences at 9-months’ follow-up
would reﬂect comparative eﬀects between patients of
physicians who received the training immediately
(intervention group) versus patients of physicians who
had not yet received the training (control group).

Randomisation and masking
To minimise uneven distribution of STI prevalence
between study groups, counties were rank-ordered within
province by HIV and STI cases and stratiﬁed into
four blocks, and we randomised counties within each
block to immediate intervention or control. Randomisation
was conducted by the project data coordinator based in
Hefei, the capital of Anhui province, with a computergenerated randomisation sequence. Allocation of county
to treatment group remained concealed until site
investigators were ready to implement the training.

Procedures
The Ai Shi Zi curriculum was developed by Chinese and
international collaborators based on comprehensive
literature reviews and consultation activities with local
and national experts, in both the USA and China. The
consultation meetings included discussions about
Chinese national guidelines for HIV and STI treatment
and infectious disease control, behavioural risk reduction
strategies, and Chinese cultural issues that can aﬀect
communication with patients. The curriculum took into
consideration the Chinese medical system by
www.thelancet.com/lancetgh Vol 4 January 2016
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54 counties approached/assessed
3 declined due to lack of time
51 counties randomised

27 counties allocated to intervention

24 counties allocated to control

121 physicians enrolled, completed
baseline assessment, and began
intervention

121 physicians completed 9-months’
follow up

633 patients recruited and
completed baseline assessment

128 physicians enrolled

491 patients recruited and
completed baseline assessment

128 physicians completed baseline
assessment, begin delayed
intervention

125 patients lost to
follow-up

508 patients completed 9-month
follow-up

28 physicians lost to
follow-up

100 physicians completed 9-month
follow-up

89 patients lost to
follow-up

402 patients completed 9-month
follow-up

Figure: Trial proﬁle

incorporating information related to the provincial
health-care structures (eg, the organisation of local
Centers for Disease Control and Prevention, county-level
and township-level hospitals) and national AIDS policies
such as access to testing and treatment.
The structure of Ai Shi Zi consisted of three major
components: (1) an initial 1-week group training held in
Hefei, Anhui Province, followed by (2) return to clinical
practice for 2 months to implement new knowledge and
skills, and (3) two additional two-day group “booster”
training sessions (at about 3 months and 6 months after
enrolment) held in Hefei. The initial group training
covered: HIV and STI biology, pathology, and
epidemiology; host immune response; opportunistic
infection and syndrome management; antiretroviral
therapy; STI treatments; behavioural risk reduction
counselling; and stigma reduction. Training methods
incorporated lectures, case studies, small group
discussions, problem-solving exercises, and role plays.
Patients with AIDS also gave presentations about their
experiences living with the disease. After the 1-week
session, participating physicians returned to their
hospital-based clinic for 2 months to practise what they
had learned, and were encouraged to maintain a journal
describing the most diﬃcult or instructive cases
encountered during clinical practice, which they would
discuss during follow-up intervention sessions. They
then reconvened in Hefei for a 2-day workshop and
practice booster session that focused on individual
www.thelancet.com/lancetgh Vol 4 January 2016

presentations and case studies of diﬃcult cases described
in their journals, group problem solving, and feedback.
Participant physicians returned again to their clinic for
2 months, maintaining a journal of diﬃcult cases, and
reconvened for a ﬁnal 2-day workshop and practice
booster session. Participant physicians completed a socalled closing ceremony, which acknowledged their
participation and encouraged the integration of their
knowledge and skills in clinical practice.
Participating physicians completed survey assessments
at baseline, immediately before every booster session
(3 months and 6 months, respectively), and at 9 months’
follow-up. Survey assessments included self-report
measures, previously validated with Chinese physicians,19
of the following: knowledge of HIV biology, testing, and
epidemiology (48 items); syndromic management
(48 items); management of opportunistic infections
(41 items); antiretroviral treatment (25 items), and
behavioural risk reduction counselling (36 items).
Patients completed baseline and 9-month assessments.
Baseline patient assessments included survey measures
of HIV and STI knowledge (25-point scale with higher
scores reﬂecting greater knowledge), attitudes towards
people with HIV (12-point scale with higher scores
reﬂecting more positive and less stigmatising attitudes),
satisfaction with their physician (7-point scale with
higher scores reﬂecting greater satisfaction), and whether
they had unprotected sex during the past 6 months.
Patient survey measures were previously validated with
e31
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patient samples in China.19 At 9 months’ follow-up,
patients completed identical surveys and provided urine
samples to retest for gonorrhoea and chlamydia. Urine
samples were transferred to the central laboratory of
Anhui Medical University. Biospecimen testing used the
ligase chain reaction test (Abbott LCx assay;
Abbott Laboratories, Abbot Park, IL, USA). Those testing
positive were contacted and oﬀered free treatment. A
random sample of 10% of specimens was retested to
check reliability.

Outcomes
The primary outcomes were combined STI (gonorrhoea
and chlamydia) reinfection rate at 9 months’ follow-up and
improvements in physician HIV/STI knowledge during
follow-up. Secondary outcomes were patients’ self-reported
measures of STI knowledge, attitudes toward people with
HIV, satisfaction with physician, and condom use during
the past 6 months.

Intervention (n=121)

Delayed control (n=128)

Domain 1: HIV/STI biology, testing, and epidemiology (48 items)
Baseline

48·7% (23·4; 0·09)

48·4% (23·2; 0·09)

3 months

63·9% (30·7; 0·10)

61·3% (29·4; 0·10)

6 months

71·5% (34·3; 0·11)

74·9% (36·0; 0·11)

9 months

72·9% (35·0; 0·12)

79·5% (38·2; 0·12)

One-way ANOVA F(3,360)=208·5; p=0·01

F(3,299)=527·0; p=0·01

Domain 2: STI syndromic management (48 items)
Baseline

49·4% (23·7; 0·13)

50·2% (24·1; 0·14)

3 months

58·7% (28·2; 0·12)

66·3% (31·8; 0·15)

6 months

67·1% (32·2; 0·16)

79·1% (38·0; 0·17)

9 months

66·6% (32·0; 0·18)

80·5% (38·6; 0·16)

One-way ANOVA F(3,360)=88·8; p=0·01

F(3,299)=515·9; p=0·01

Domain 3: Management of opportunistic infections (41 items)
Baseline

38·1% (15·6; 0·11)

39·1% (16·0; 0·09)

3 months

60·3% (24·7; 0·18)

48·3% (19·8; 0·12)

6 months

64·4% (26·4; 0·16)

57·2% (23·4; 0·15)

9 months

64·3% (26·4; 0·17)

62·8% (25·8; 0·15)

One-way ANOVA F(3,360)=118·8; p=0·01

F(3,299)=231·6; p=0·01

Domain 4: Antiretroviral treatment (25 items)
Baseline

33·6% (8·40; 0·11)

34·8% (8·70; 0·10)

3 months

51·3% (12·8; 0·12)

42·7% (10·7; 0·15)

6 months

53·4% (13·3; 0·15)

48·2% (12·1; 0·17)

9 months

55·1% (13·8; 0·15)

52·2% (13·1; 0·18)

One-way ANOVA F(3,360)=113 00; p=0 01

F(3,299)=81·2; p=0·01

Domain 5: Risk reduction counselling (36 items)
Baseline

42·9% (15·5; 0·15)

40·9% (14·7; 0·14)

3-months

64·3% (23·4; 0·16)

66·1% (23·8; 0·17)

6-months

74·5% (26·8; 0·17)

83·3% (30 0; 0·14)

9-months

76·7% (27·6; 0·17)

90·4% (32·6; 0·09)

One-way ANOVA F(3,360)=469·5; p=0·01

F(3,299)=785·8; p=0·01

Data are % correct (M items correct; SD). STI=sexually transmitted infection.

Table 1: Physician HIV/STI knowledge domains at baseline, 3 months’,
6 months’, and 9 months’ follow-up by intervention (n=249)
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Statistical analysis
The sample size calculation was based on our primary
hypothesis concerning patient outcomes. From
preliminary data derived from our Ai Shi Zi pilot study,
conducted in diﬀerent Anhui counties from those
included in this trial,19 we hypothesised that patients in
the intervention group would have a 30% reduction in
combined STI reinfection compared with patients in the
control group. With an estimated interclass correlation
coeﬃcient of 0·01 based on our pilot, this trial required a
sample size of 480 patients per group to provide power of
0·80 at a signiﬁcance of 0·05 to test our primary
hypothesis. We planned to recruit four patients per
physician, requiring 120 physicians per group.
To assess whether the intervention led to improvements
in physicians’ knowledge, we conducted one-way
repeated measures ANOVAs to assess the number
of items answered correctly for each physician knowledge
domain (HIV/AIDS biology, testing, epidemiology; STI
syndromic management; management of opportunistic
infections; antiretroviral treatment; risk reduction
counselling). We expected physicians in both intervention
and control groups to show improvements at follow-up
on all ﬁve knowledge domains.
Due to the hierarchical structure of the design (patients
nested within physicians nested within counties), we used
mixed eﬀects multilevel logistic regression models for
binary outcomes and ordinary least squares regression
models for continuous outcomes to account for countylevel and physician-level clustering. All regressions also
adjusted for basic patient sociodemographic characteristics
(sex, marital status, employment status). We calculated
variance across county and physician levels according to
the speciﬁed outcomes, and we undertook regression
diagnostics, including calculating intraclass correlation
values, to assess goodness of ﬁt. We undertook regression
analyses with an intention-to-treat approach and used the
last observation carried forward technique to account for
the 20% missing follow-up data on study outcomes. Data
were analysed with Stata (version 11.1).
This study is registered with ClinicalTrials.gov,
NCT00644150.

Role of the funding source
The funder had no role in the study design, data collection,
data analysis, data interpretation, or writing of the report.

Results
Between April 1, 2007, and Sept 1, 2008, we approached
54 administrators of county-level general hospitals, of
whom 51 (39 from Anhui province and 12 from Jiangsu
province) expressed interest; three declined due to lack of
time. 27 were randomly assigned to the intervention
group and 24 to control. 249 physicians from the
51 county-level hospitals were enrolled. Of these,
121 physicians were in the intervention group, all of
whom were reassessed at 9 months, and 128 physicians
www.thelancet.com/lancetgh Vol 4 January 2016
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Combined STI
n/N (%)
Intervention
Control

Gonorrhoea

Chlamydia

AOR (95% CI)

n/N (%)

AOR (95% CI)

n/N (%)

AOR (95% CI)

0·62 (0·46–0·84)

44/508 (9%)

0·68 (0·49–0·60)

39/508 (8%)

0·79 (0·56–1·12)

1·00

92/402 (23%)

1·00

75/402 (19%)

1·00

58/508 (11%)
123/402 (31%)

Multilevel models adjusted for county and physician levels. STI=sexually transmitted infection.

Table 2: Eﬀects of intervention on STI (gonorrhoea or chlamydia) reinfection at 9 months’ follow-up

Unprotected sex, past
6 months*

HIV knowledge

Attitudes towards people
with HIV

Physician communication

Study group
Intervention

0·10 (0·12 to 0·42)

2·13 (1·52 to 2·73)

1·51 (0·97 to 2·05)

0·22 (0·15 to 0·30)

Delayed control

1·00

1·00

1·00

1·00

Male

1·32 (0·77 to 2·25)

0·07 (–0·46 to 0·59)

0·25 (–0·24 to 0·75)

0·03 (–0·01 to 0·07)

Female

1·00

1·00

1·00

1·00

Sex

Marital status
Never married

1·00

Married

2·23 (1·36 to 3·65)

1·00

1·00

Divorced or separated

0·48 (0·20 to 1·19)

–1·50 (–2·72 to –0·29)

–2·09 (–3·24 to –0·94)

–0·03 (–0·12 to 0·07)

Widowed

··

–3·45 (–6·23 to –0·67)

–0·14 (–2·78 to 2·48)

–0·07 (–0·25 to 0·12)

–0·14 (–0·62 to 0·34)

0·01 (–0·02 to 0·05)

–1·04 (–1·58 to –0·50)

–0·79 (–1·31 to –0·28)

1·00
0·001 (–0·04 to 0·04)

Employment
Yes

0·85 (0·51 to 1·41)

0·64 (0·13 to 1·14)

No

1·00

1·00

1·00

1·00

Data are *AOR (95% CI) or adjusted β (95% CI). Multilevel models adjusted for county and physician levels. AOR=adjusted odds ratio.

Table 3: Intervention eﬀects on patient unprotected sex, HIV knowledge, attitudes towards people with HIV, and communication with physician

were in the control group, of whom 100 (78%) were
reassessed at 9 months (ﬁ
ﬁgure
gure). No diﬀerences were
noted in baseline measures between physicians who
completed the 9-month assessment versus those who did
not complete the 9-month assessment.
Table 1 shows descriptive physician scores on the
ﬁve assessed HIV knowledge domains. Baseline
knowledge scores did not diﬀer between intervention
and control groups. As expected, we noted improvements
in both intervention group and control groups for all
domains: HIV/STI biology, testing, and epidemiology
(p=0·01); STI syndromic management (p=0·01);
management of opportunistic infections (p=0·01);
antiretroviral treatment (p=0·01); and risk reduction
counselling (p=0·01; table 1).
1124 patients were recruited from participating
physicians. Of these, 862 (77%) were men, 1072 (95%)
were of Han ethnicity, 878 (78%) were from
Anhui province, 785 (70%) were educated below the high
school level, 842 (75%) were currently employed, and
850 (76%) were married. No signiﬁcant baseline
diﬀerences in sociodemographic characteristics were
noted between the intervention and control patients. Of
633 patients in the intervention group at baseline,
508 (80%) were reassessed at 9 months; of 491 patients in
the control group at baseline, 402 (82%) were reassessed
at 9 months. No signiﬁcant sociodemographic diﬀerences
www.thelancet.com/lancetgh Vol 4 January 2016

were noted between patients who completed versus those
who did not complete the 9-month assessment.
At baseline, 910 (81%) of 1124 patients tested positive
for gonorrhoea or chlamydia (or both): 508 (77%) of
663 in the intervention group and 402 (82%) of 491 in the
control group. 838 (75%) of 1124 patients tested positive
for gonorrhoea (475 [75%] of 633 patients in the
intervention group vs 363 (74%) of 491 patients in the
control group) and 598 (53%) of 1124 tested positive for
chlamydia (356 [56%] of 633 patents in the intervention
group vs 242 [49%] of 491 patients in the control group.
Baseline group diﬀerences in patient gonorrhoea and
chlamydia were not statistically signiﬁcant; all patients
who were infected with gonorrhoea and chlamydia at
baseline were treated. At 9-month follow-up, after
adjustment for county and physician levels, patients in
the intervention group had signiﬁcantly lower odds of
combined STI (gonorrhoea or chlamydia) and
gonorrhoea reinfection only at 9 months’ follow-up
(table
table 2). Group diﬀerences in 9-month chlamydia
reinfection were not statistically signiﬁcant (table 2).
Table 3 shows the eﬀects of the intervention on patients’
follow-up levels of unprotected sex during the past
6 months, HIV knowledge, attitudes towards people
living with HIV, and physician communication. In
multilevel regression, which adjusted for county and
physician levels, we noted that patients in the intervention
e33
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group at follow-up were signiﬁcantly less likely to report
unprotected sex during the past 6 months than were
control patients (426/508 vs 382/402; table 3). Intervention
patients also had signiﬁcantly higher HIV/STI knowledge
scores (M=16·8 [SD 3·10]) compared with control
patients (M=14·91 [SD 3·19]; table 3); and higher
physician satisfaction (M=2·43 [SD 0·22]) compared
with control patients (M=2·29 [SD 0·54]; table 3).
Although not statistically signiﬁcant, attitudes towards
people living with HIV tended to be moderately more
positive among intervention patients (M=8·50 [SD 3·43])
compared with control patients (M=7·15 [SD 3·10];
table 3). In these multilevel mixed-eﬀects logistic models,
which included county and physician levels, county level
accounted for 19–26% of the total variance and physician
level accounted for 17–20% of the total variance,
depending on the choice of outcome. On the basis of
these regression diagnostics and the ICC values, these
models show reasonable goodness of ﬁt.
No harms were reported during the conduct of this trial.

Discussion
Training physicians in China on HIV and STI knowledge,
treatment, and risk reduction counselling, and
motivating them to integrate prevention and treatment
into routine care resulted in lower reinfection with
gonorrhoea and chlamydia in patients at 9 months
(panel). Patients of physicians who received the training
had 38% lower odds of combined gonorrhoea and
chlamydia reinfection and 32% lower odds of gonorrhoea
reinfection alone compared with patients of physicians
in the delayed control. The protective intervention eﬀect
trend for chlamydia reinfection alone was not statistically
signiﬁcant, suggesting either that the non-signiﬁcant
eﬀect was due to chance or that our sample size was
inadequate to determine a deﬁnitive beneﬁt . We suspect
the latter, in view of the signiﬁcant eﬀect of the
intervention on the combined STI and gonorrhoea-alone
endpoints. Eﬀects on HIV incidence were not assessed
owing to the prohibitive sample size needed to determine
such an eﬀect. Patients of physicians who received the
training also reported 78% lower odds of unprotected sex
during the past 6 months as well as signiﬁcantly
improved HIV and STI knowledge, attitudes towards
people living with HIV, and satisfaction with physicians.
To our knowledge, this is the ﬁrst study in China that
uses a randomised trial to assess the eﬀects of physician
HIV and STI training on indicators of patient-level
biological, behavioural, and sociocognitive risk.
There were several unique features of the Ai Shi Zi
programme that could have contributed to the observed
eﬀects. First, the programme recognised and included
up-to-date information about national AIDS policies and
local health infrastructure, including availability and
guidelines for HIV medications and STI treatment,
which can aﬀect service provision for patients. Second,
the programme included culturally sensitive information
e34

about risk reduction counselling, stigma towards people
living with HIV, and traditional norms and beliefs that
can inﬂuence physicians’ interactions with patients.
Presentations by local patients with AIDS about their
perspectives on health care, stigma, and living with the
disease could have been particularly relevant to this
programme. Third, the programme incorporated several
strategies to train physicians and model new skills. For
example, interactive learning strategies complemented
didactic lectures, which tend to be the dominant mode of
instruction in China. Fourth, booster sessions provided
additional opportunities for problem solving, feedback,
and professional support.
Findings from the Ai Shi Zi project are consistent with
studies done in the USA showing the role of physician
training to reduce HIV transmission risk among patient
populations. For example, a randomised trial of a brief
4-h training for medical providers on behavioural risk
counselling with HIV-positive patients noted signiﬁcantly
increased provider-patient discussions of safer sex and
reduced number of sex partners among patients
compared with patients of physicians who were not
trained.26 Similar studies have shown the eﬀects of
provider-initiated safer sex counselling to HIV-positive or
at-risk patients on behavioural risk reduction outcomes
compared with patients in control groups without
provider-initiated counselling.27,28 These studies align
with recommendations by the US CDC for the integration
of routine HIV and STI assessment and risk reduction
counselling in clinical settings serving HIV-infected
populations.29 Based on ﬁndings from Ai Shi Zi,
integration of HIV and STI prevention into routine care
for risk populations in China could be warranted.
Due to stigma, traditional cultural beliefs, and
inadequate institutional support, physicians in China
might experience challenges to HIV and STI-related
service provision.30 Results from Ai Shi Zi, and a related
intervention shown to reduce HIV stigma in Chinese
physicians entitled “White Coat, Warm Heart”,21 indicate
that these challenges can be overcome by programmatic
eﬀorts to engage physicians, provide educational
training and support, and shift norms around services
for HIV-risk patient populations. Questions remain,
however, regarding the speciﬁc strategies needed to
broadly disseminate and implement these programmes.
“White Coat, Warm Heart” involved four group training
sessions over a 1-month period and three additional
booster sessions, whereas Ai Shi Zi involved a 1-week
group training and two additional booster sessions.
Speciﬁc training components that contributed to
intervention eﬀects have not been identiﬁed in either
study. Because of programme length and complexity,
institutional support, and training resources will be
needed to scale up these training programmes. In
addition to eﬀorts to improve physician training, public
health strategies such as partner tracing, partner
notiﬁcation, and partner treatment might enhance
www.thelancet.com/lancetgh Vol 4 January 2016
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identiﬁcation and prevention of HIV and STI cases in
China, and warrant further study.
Limitations to this research must be considered. The
study used a brief 9-month follow-up, and we cannot
comment on longer-term eﬀects. There might be
limitations in representativeness and generalisability of
study ﬁndings owing to selection biases and nonmonetary incentives (eg, paid trip to Hefei for
professional training) among physicians who agreed to
participate; we also do not have information about the
size of the full sampling frame of physicians, and cannot
determine the proportion of physicians represented in
this study. We undertook the training in county hospitals
that allowed for recruitment and physician participation;
ﬁndings might not generalise to hospital settings where
physicians do not have institutional support to
participate. Patients were recruited from waiting areas of
participating physicians, and these patients might not
represent those who do not seek health services. Patient
attrition levels were high and study ﬁndings might be
less reliable due to the amount of missing data (20%);
challenges in patient retention might possibly reﬂect
high levels of internal migration. We did not observe or
collect data about the clinical encounters between trained
physicians and patients, and so we cannot specify
the exact physician-level factors that inﬂuenced
improvements in patient outcomes. We did not collect
detailed information about physician demographic
backgrounds and thus are unable to examine physician
background characteristics that might moderate
the intervention eﬀects. There might have been
contamination such that control participants later in the
trial might have been exposed to intervention content.
We sampled only 10% of biospecimens for reliability.
Biological results might not be generalisable to other
STIs, including HIV or syphilis.
In summary, this research provides empirical support
for the eﬃcacy of physician training on HIV and STI
knowledge, treatment, and risk reduction counselling as
a strategy to prevent HIV risk and STI reinfection in
China. Future analyses based on this trial should provide
greater understanding of the behavioural mechanisms,
psychosocial factors, and patient characteristics that
contributed to the intervention eﬀects. For example, the
intervention is likely to have led to improved patientphysician communication, higher levels of patient selfeﬃcacy, and greater levels of patient awareness about
HIV risk. Intervention eﬀect moderators will also be
examined, including patient characteristics such as sex,
marital status, and socioeconomic status, to identify
whether the intervention has greater eﬀect on speciﬁc
subgroups. A report on the implementation processes,
content, and curricula is also planned.
As HIV and STI epidemics in China continue to
expand, strategic interventions are needed to reach those
populations at highest risk.31 Improvement in HIV and
STI expertise in the next generation of health providers
www.thelancet.com/lancetgh Vol 4 January 2016
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Systematic review
In September, 2004, at the time of planning this trial, we searched the published literature
indexed in PubMed with the terms ‘‘HIV AND intervention AND physician AND China’’
and found no randomised controlled trials evaluating an intervention to train physicians
in China on HIV and STI prevention. We searched PubMed again in July, 2015, to identify
relevant research at the time of ﬁnal analysis. Although we were unable to identify
published clinical trials in this area of research, we identiﬁed three studies18–20 that have
shown feasibility and preliminary eﬀects of programmes to train Chinese physicians on
HIV knowledge. However, these studies did not have control groups or patient-level
biological outcomes. Another identiﬁed study21 used a randomised control trial to test an
HIV stigma reduction intervention for physicians in China, and noted signiﬁcant
reductions in stigmatising attitudes and behaviours among physicians. However, this
study did not examine patient-level HIV or STI behavioural or biological outcomes.
Conclusions from a recently published systematic review of HIV interventions in China
further highlight an absence of evidence on the eﬀectiveness of physician training on HIV
and STI behavioural or biological outcomes.31
Interpretation
This study provides the ﬁrst evidence, to our knowledge, for the eﬀectiveness of training
physicians on HIV and STI prevention in China. Findings showed promising eﬀects of
physician intervention training on patient STI reinfection and self-reported HIV risk
behaviours. Speciﬁcally, ﬁndings showed that patients of physicians who received the
training had lower STI reinfection, lower unprotected sex, and greater physician
satisfaction compared with patients of physicians who had not received the training.
These ﬁndings indicate the importance of incorporating education on HIV and STI
prevention and treatment in medical education in China.

in China is one such strategy, yet requires institutional
and political commitment, in terms of human resources,
educational investments, and motivation for engagement
in training. In view of the sheer size and reach of the
HIV and STI epidemics in China, such investments are
likely to have considerable public health and populationlevel beneﬁts.
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